Tariff Stocks: 20 Stocks to Benefit From Onshoring Boom

Page 10 of 20

11. AstraZeneca PLC (NASDAQ:AZN)

Number of Hedge Fund Holders: 56

AstraZeneca PLC (NASDAQ:AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) announced on July 21 that it would invest $50 billion in the United States by 2030, becoming the most recent pharmaceutical company to make this commitment as impending tariffs threaten to drive up costs in the sector.

The company claims that plans for a new production facility specializing in chronic illnesses are part of the investment. The multibillion-dollar facility would support the company’s oral GLP-1s and the company’s metabolic and weight-management portfolio.

According to the company, the Virginia plant would be AstraZeneca’s biggest manufacturing investment in the world. The investments coincide with President Trump’s threats of levying tariffs of up to 200% on medications manufactured overseas. Before the tariffs take effect, companies would have up to a year and a half to reshore their supply lines.

AstraZeneca PLC (NASDAQ:AZN) is a prominent player in the pharmaceutical sector, especially for its work on rare disease and cancer treatments. The company has a strong reputation in the healthcare industry thanks to its history of medical advancements.

Page 10 of 20